| Vasudha Shah, PHARMD | |
|
8861 Greenback Ln, Orangevale, CA 95662-4058 | |
| (650) 336-3219 | |
| Not Available |
| Full Name | Vasudha Shah |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 8861 Greenback Ln, Orangevale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750993879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 82910 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vasudha Shah, PHARMD 8861 Greenback Ln, Orangevale, CA 95662-4058 Ph: () - | Vasudha Shah, PHARMD 8861 Greenback Ln, Orangevale, CA 95662-4058 Ph: (650) 336-3219 |
News Archive
New data presented today at Obesity 2010, the 28th annual scientific meeting of The Obesity Society, find that bariatric surgery is associated with reduced healthcare costs for diabetes patients who are morbidly obese.
Researchers from North Carolina State University have found a link between a mutation in a gene called RAB 24 and an inherited neurodegenerative disease in Old English sheepdogs and Gordon setters. The findings may help further understanding of neurodegenerative diseases and identify new treatments for both canine and human sufferers.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today favorable data from further analysis of its Phase II/III double-blind, placebo-controlled study designed to test the efficacy of CF101 in patients with moderate-to-severe plaque psoriasis.
For women with metastatic breast cancer who had elevated amounts of circulating tumor cells (CTCs) in their blood after a first line of chemotherapy, switching immediately to a different chemotherapy did not improve overall survival or time to progression, according to the results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
› Verified 8 days ago
Dr. Liliya Borichevskiy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8961 Greenback Ln, Orangevale, CA 95662 Phone: 916-989-9380 | |
Dr. Marjan Rahnejat, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8900 Greenback Ln, Orangevale, CA 95662 Phone: 916-990-0500 Fax: 916-990-0734 | |
Dr. Pretesh Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8961 Greenback Ln, Orangevale, CA 95662 Phone: 916-989-9380 Fax: 916-989-9382 | |
A Rim Park, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8861 Greenback Ln, Orangevale, CA 95662 Phone: 916-989-4001 | |
Dr. Parisa Alavi, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8900 Greenback Ln, Orangevale, CA 95662 Phone: 916-990-0500 | |
Jeanne Pak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8961 Greenback Ln, Orangevale, CA 95662 Phone: 916-989-9380 | |
Farzaneh Sara Agahi, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8465 N Star Way, Orangevale, CA 95662 Phone: 916-224-5882 |